Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Balicatib in Postmenopausal Osteoporosis
NCT00100607Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of balicatib in osteoporosis, sponsored by Novartis. Started Feb 2004; status: completed.
02
Drugs
balicatib
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00100607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00100607.